Tradestie Institutional Equity Comparison Engine

ADUS vs ARDT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ARDT Overall Edge

ARDT Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“7 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ardent Health, Inc. (ARDT) driven by superior Valuation, Momentum & Technical while ADUS counters with relative strength in Growth & Margin. Fundamentally, ADUS trades at 16.1x Forward P/E with 10.4% operating margin (+7.0% YoY revenue) versus ARDT at 10.9x Forward P/E and 5.1% operating margin (+3.1% YoY). In options structure, ADUS sits in UNCLASSIFIED (16th %ile IV; Dealer Gamma Walls on Pro) against ARDT sits in UNCLASSIFIED (16th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ARDT
ADUS 16.1x vs ARDT 10.9x Fwd P/E
Growth & Margin Winner ADUS
Op Margin 10.4% vs 5.1% ยท YoY +7.0% vs +3.1%
Momentum & Technical Winner ARDT
1Y +12.4% vs +74.7% ยท 52W Pos 79% vs 68%
Options & Structure Winner Tie
UNCLASSIFIED (16th %ile IV) vs UNCLASSIFIED (16th %ile IV)
ADUS NASDAQ
Addus HomeCare Corp.
Services-Home Health Care Services
$122.50
+1.18% 1D
Market Cap $2.3B
1M Return -0.14%
1Y Return +12.39%
Forward P/E 16.1x
Unified AI Score
59.0 / 100 HOLD
Tech 57.0 Fund 52.0 Flow 50.0 Mom 46.0
ARDT NYSE
Ardent Health, Inc.
Services-General Medical & Surgical Hospitals, Nec
$15.08
+4.0% 1D
Market Cap $2.0B
1M Return +22.01%
1Y Return +74.74%
Forward P/E 10.9x
Unified AI Score
40.2 / 100 SELL
Tech 15.0 Fund 38.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ADUS +12.39% ARDT +74.74% Spread: +62.35 pp (ARDT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ADUS TTM Op. Margin: 10.4% ARDT TTM Op. Margin: 5.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ADUS vs ARDT. Trailing 12-month operating profitability (ADUS 10.4% vs ARDT 5.1%) and valuation multiples (ADUS 16.1x vs ARDT 10.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ADUS (7) vs ARDT (3)
Institutional Metric ADUS ARDT Criterion Row Winner
Market Capitalization Scale $2.3B $2.0B Larger Scale ADUS
Trailing P/E Ratio Valuation 20.1x 14.1x Lower Multiple ARDT
Forward P/E Ratio Valuation 16.1x 10.9x Lower Multiple ARDT
Revenue Growth (YoY) Growth +7.0% +3.1% Higher Growth ADUS
Operating Margin (TTM) Profitability 10.4% 5.1% Higher Margin ADUS
Net Profit Margin Profitability 7.4% 2.3% Higher Margin ADUS
Return on Equity (ROE) Capital Efficiency 10.0% 13.5% Higher ROE ARDT
52-Week Range Position Momentum 79% ($88โ€“$132) 68% ($8โ€“$19) Stronger Trend ADUS
Beta / 30D Volatility Risk Regime -0.07ฮฒ ยท 21% Vol 0.01ฮฒ ยท 115% Vol Lower Realized Risk ADUS
Unified Institutional Score Composite Signal 59.0 / 100 (HOLD) 40.2 / 100 (SELL) Higher Composite ADUS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ADUS vs ARDT Buy Guide
ADUS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live ADUS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ARDT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live ARDT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ADUS nor ARDT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.